Works matching IS 00348376 AND DT 2022 AND VI 74 AND IP 1

Results: 7

CARDIOVASCULAR RISK PREDICTION MODELS IN PEOPLE LIVING WITH HIV IN COLOMBIA.
Published in:
Clinical & Translational Investigation / Revista de Investigación Clínica, 2022, v. 74, n. 1, p. 23, doi. 10.24875/RIC.21000251
By:
- GARCÍA-PEÑA, ANGEL A.;
- DE-VRIES, ESTHER;
- ALDANA-BITAR, JAIRO;
- CÁCERES, EDWARD;
- BOTERO, JUAN;
- VÁSQUEZ-JIMÉNEZ, JUAN;
- TAMARA, ROBERTO;
- OLEJUA, PETER
Publication type:
Article
IMPACT OF COVID-19 ON THE DIAGNOSIS AND MANAGEMENT OF MULTIPLE MYELOMA: EXPERIENCE FROM A CANADIAN CENTER.
Published in:
Clinical & Translational Investigation / Revista de Investigación Clínica, 2022, v. 74, n. 1, p. 16, doi. 10.24875/RIC.21000347
By:
- JIMENEZ-ZEPEDA, VICTOR H.;
- YAU, PATRICK;
- STEWART, DOUGLAS;
- BERHAN, JOWHER;
- CHAMBERS, CAROLE;
- LEE, HOLLY;
- TAY, JASON;
- DUGGAN, PETER;
- MCCULLOCH, SYLVIA;
- NERI, PAOLA;
- BAHLIS, NIZAR
Publication type:
Article
ADAPTATION TO MODERATE ALTITUDE HYPOXEMIA: THE EXAMPLE OF THE VALLEY OF MEXICO.
Published in:
Clinical & Translational Investigation / Revista de Investigación Clínica, 2022, v. 74, n. 1, p. 4, doi. 10.24875/RIC.21000159
By:
- PÉREZ-PADILLA, JOSÉ R.
Publication type:
Article
SPLITTING THE TOTAL DOSE OF CYCLOPHOSPHAMIDE IN TWO BLOCKS APART DURING THE CONDITIONING OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS RESULTS IN DIMINISHED CARDIOTOXICITY: EXPERIENCE IN 1,000 PATIENTS.
Published in:
Clinical & Translational Investigation / Revista de Investigación Clínica, 2022, v. 74, n. 1, p. 1, doi. 10.24875/RIC.21000206
By:
- OLIVARES-GAZCA, JUAN CARLOS;
- GUERRERO-PESQUEIRA, FRANCISCO;
- MURRIETA-ALVAREZ, IVÁN;
- CANTERO-FORTIZ, YAHVETH;
- LEÓN-PEÑA, ANDRÉS A.;
- PRIESCA-MARÍN, JOSÉ M.;
- GOMEZ-ALMAGUER, DAVID;
- GOMEZ-DE-LEON, ANDRÉS;
- RUÍZ-DELGADO, GUILLERMO J.;
- RUIZ-ARGÜELLES, GUILLERMO J.
Publication type:
Article
HOSPITAL ARRIVAL AND FUNCTIONAL OUTCOME AFTER INTRACEREBRAL HEMORRHAGE.
Published in:
Clinical & Translational Investigation / Revista de Investigación Clínica, 2022, v. 74, n. 1, p. 51, doi. 10.24875/RIC.21000471
By:
- RUIZ-SANDOVAL, JOSÉ L.;
- ACEVES-MONTOYA, JAVIER;
- CHIQUETE, ERWIN;
- LÓPEZ-VALENCIA, GERMÁN;
- LARA-LÓPEZ, ALEJANDRO;
- SÁNCHEZ-GONZÁLEZ, MANUEL;
- JIMÉNEZ-RUIZ, AMADO;
- BARINAGARREMENTERIA, FERNANDO;
- MURILLO-BONILLA, LUIS;
- ARAUZ-GÓNGORA, ANTONIO;
- FLORES-SILVA, FERNANDO DANIEL;
- SILVA, CARLOS CANTÚ-BRITO
Publication type:
Article
EFFECT OF TOCILIZUMAB IN MORTALITY AMONG PATIENTS WITH SEVERE AND CRITICAL COVID-19: EXPERIENCE IN A THIRD-LEVEL MEDICAL CENTER.
Published in:
Clinical & Translational Investigation / Revista de Investigación Clínica, 2022, v. 74, n. 1, p. 40, doi. 10.24875/RIC.21000404
By:
- MARTÍNEZ-GUERRA, BERNARDO A.;
- DE-LEÓN-CMDANES, NEREYDA A.;
- TAMEZ-TORRES, KARLA M.;
- ROMÁN-MONTES, CARLA M.;
- RAJME-LÓPEZ, SANDRA;
- ORTIZ-BRIZUELA, EDGAR;
- AGUILAR-SALINAS, CARLOS A.;
- SIERRA-MADERO, JUAN;
- SIFUENTES-OSORNIO, JOSÉ;
- PONCE-DE-LEÓN, ALFREDO;
- GONZÁLEZ-LARA, MARÍA F.
Publication type:
Article
SCREENING ANTI-INFLAMMATORY, ANTICOAGULANT, AND RESPIRATORY AGENTS FOR SARS-COV-2 3CL<sup>PRO</sup> INHIBITION FROM CHEMICAL FINGERPRINTS THROUGH A DEEP LEARNING APPROACH.
Published in:
Clinical & Translational Investigation / Revista de Investigación Clínica, 2022, v. 74, n. 1, p. 31, doi. 10.24875/RIC.21000282
By:
- SILVEIRA, ELENA CAIRES
Publication type:
Article

Works matching IS 00348376 AND DT 2022 AND VI 74 AND IP 1

CARDIOVASCULAR RISK PREDICTION MODELS IN PEOPLE LIVING WITH HIV IN COLOMBIA.

IMPACT OF COVID-19 ON THE DIAGNOSIS AND MANAGEMENT OF MULTIPLE MYELOMA: EXPERIENCE FROM A CANADIAN CENTER.

ADAPTATION TO MODERATE ALTITUDE HYPOXEMIA: THE EXAMPLE OF THE VALLEY OF MEXICO.

SPLITTING THE TOTAL DOSE OF CYCLOPHOSPHAMIDE IN TWO BLOCKS APART DURING THE CONDITIONING OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS RESULTS IN DIMINISHED CARDIOTOXICITY: EXPERIENCE IN 1,000 PATIENTS.

HOSPITAL ARRIVAL AND FUNCTIONAL OUTCOME AFTER INTRACEREBRAL HEMORRHAGE.

EFFECT OF TOCILIZUMAB IN MORTALITY AMONG PATIENTS WITH SEVERE AND CRITICAL COVID-19: EXPERIENCE IN A THIRD-LEVEL MEDICAL CENTER.

SCREENING ANTI-INFLAMMATORY, ANTICOAGULANT, AND RESPIRATORY AGENTS FOR SARS-COV-2 3CL<sup>PRO</sup> INHIBITION FROM CHEMICAL FINGERPRINTS THROUGH A DEEP LEARNING APPROACH.